Bristol Myers Squibb Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Bristol Myers Squibb stocks.

Bristol Myers Squibb Stocks Recent News

Date Stock Title
May 16 CTMX CytomX Therapeutics Announces New Employment Inducement Grants
May 16 BMY Walmart Earnings & the State of the Consumer
May 16 BMY Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
May 16 SNY Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
May 16 SNY Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
May 16 BMY New Four-Year Sotyktu (deucravacitinib) Data Demonstrate Durable Response Rates and Consistent Safety in Moderate-to-Severe Plaque Psoriasis
May 16 SNY If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now
May 16 BMY Bristol Myers (BMY) Gets FDA Nod for Breyanzi Label Expansion
May 16 BMY FDA approves Bristol Myers Squibb’s Breyanzi for follicular lymphoma
May 16 BMY Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma
May 15 BMY Bristol-Myers Squibb Company (BMY) Bank of America Global Healthcare Conference 2024 Transcript
May 15 BMY Tudor Investment's top buys and sells in Q1
May 15 BMY Bristol Myers' Breyanzi gains additional indication for follicular lymphoma
May 15 BMY UPDATE 3-US FDA approves expanded use of Bristol Myers' cancer cell therapy
May 15 SNY Novavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?
May 15 SNY Novavax Stock Just Tripled. Is It Too Late to Buy?
May 14 RAPT Wolfe downgrades RAPT, but still sees "immense" upside potential
May 14 SNY Sanofi to make €1bn biomanufacturing investment in France
May 14 SNY Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
May 14 SNY Trending tickers: Anglo American, GameStop, Vodafone, Greggs and Novavax
Bristol Myers Squibb

Bristol-Myers Squibb Company (BMS) is an American pharmaceutical company, headquartered in New York City.
Bristol-Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.
BMS' primary R&D sites are located in Lawrence, New Jersey (formerly Squibb, near Princeton) and Wallingford, Connecticut (formerly Bristol-Myers); with other sites in East Syracuse, New York; Princeton Pike, Hopewell Township and New Brunswick, New Jersey; and in Swords, Ireland; Braine-l'Alleud, Belgium; Tokyo, Japan; and Bangalore, India.

Browse All Tags